Galvezo, Jhayfford .
HRN: 22-35-63 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
12/27/2022
01/02/2023
ORAL
5ml
Q8Hrs
URTI
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes